Elanco Animal Health (ELAN) Common Equity (2017 - 2026)

Elanco Animal Health (ELAN) has 10 years of Common Equity data on file, last reported at $6.5 billion in Q1 2026.

• For the quarter ending Q1 2026, Common Equity rose 2.31% year-over-year to $6.5 billion; the trailing twelve-month figure through Mar 2026 stood at $6.5 billion (up 2.31% YoY), and the FY2025 full-year result was $6.5 billion, up 7.4% from the prior year.
• Common Equity fell to $6.5 billion in Q1 2026, from $6.5 billion in the prior quarter.
• In the past five years, Common Equity ranged from a high of $7.6 billion in Q1 2022 to a low of $5.9 billion in Q2 2024.
• A 5-year average of $6.7 billion and a median of $6.5 billion in 2025 frame the typical range for Common Equity.
• Across the five-year window, Common Equity dropped 19.92% in 2024 and increased 14.02% in 2025, its largest moves.
• Tracing ELAN's Common Equity over 5 years: stood at $7.3 billion in 2022, then slipped by 14.62% to $6.2 billion in 2023, then slipped by 2.04% to $6.1 billion in 2024, then advanced by 7.4% to $6.5 billion in 2025, then slipped by 0.72% to $6.5 billion in 2026.
• Business Quant data shows ELAN's Common Equity at $6.5 billion in Q1 2026, $6.5 billion in Q4 2025, and $6.7 billion in Q3 2025.